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A R T I C L E   I N F O S U M M A R Y 
Raman microscopy was used to visualize the integrity of a barrier membrane coating 
at the various stage of chewable tablets development. The effect of substrate 
morphology and particle characteristics was found to be important in maintaining 
the integrity of the coating throughout the process of chewable tablets manufacture. 
Furthermore, the observations from the Raman image analysis provide an 
understanding of the factors affecting drug release. 
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INTRODUCTION 
The effective taste masking of particles for 
incorporation into chewable dosage forms is 
influenced by the consistency and integrity of the 
applied barrier membrane coating. During the tablet 
compression process, the coating around the drug 
particles may fracture, leading to an adverse taste 
profile in the final dosage form. In addition to the 
barrier coating composition and application levels, 
the substrate morphology, strength and particle size 
also influence the final integrity of the coated particles 
(Pearnchob and Bodmeier, 2003; Terebesi and 
Bodmeier, 2010). In this study, Raman microscopy 
was used to generate images and visualize the 
integrity of barrier membrane coatings on two 
different grades of acetaminophen (APAP) granules 
with differing morphologies. Raman imaging was 
used to evaluate granule characteristics from each 
stage of the manufacturing process, from coating to 
blending to compression. Further, the observations 
from the Raman image analysis were correlated with 
in vitro drug release. 
MATERIALS AND METHODS 
Two grades of APAP, Compap (amorphous, spray 
dried, d(50): 181µm) and special granular (crystalline 
granules, d(50): 332µm) (Covidien, USA) were coated 
using Surelease® aqueous ethylcellulose dispersion 
combined with a hypromellose-based Opadry® 
(Colorcon Inc., West Point, USA) as a pore former, at 
a ratio of 85:15 w/w. The coating was applied to the 
granules using a top spray fluid bed coater (Glatt 
GPCG-2) up to 30% weight gain (WG). The coated 
APAP granules of both morphologies were each 
blended with Parteck® ODT (Merck KGaA, DE), 
sweetener, disintegrant, glidant and lubricant and 
compressed to form the chewable APAP tablets. 
The coated APAP granules, tableting blend and 
compressed APAP chewable tablets were observed 
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under a Raman microscope (Horiba LabRamHR) to 
examine the integrity of the barrier membrane coating 
around the particles. Further, in vitro dissolution 
studies for the coated granules, tableting blend and 
compressed chewable tablets were carried out using 
USP Apparatus II (paddles) at 75 rpm in 900 ml of 
pH5.8 phosphate buffer. Drug release was determined 
spectrophotometrically at a wavelength of 243 nm. 
RESULTS AND DISCUSSION 
Raman images of the coated granules confirmed the 
presence of the coating surrounding the particle 
surfaces for both grades of APAP (Fig 1). However, 
non-uniformity of the coating around the edges of the 
irregular shaped Compap granules was also 
observed. Raman imaging comparing coated granules 
in the tableting blend and after compression into 
chewable tablets indicated some breakage/ 
elimination of the coating from the particle surface 
after compression. However, this breakage was much 
more pronounced with the irregular shaped Compap 
granules compared to the more regular shaped 
crystalline granule surface. 
 
Fig. 1. Raman Imaging of Coated APAP Granules before 
compression (top) and after compression (bottom). 
Dissolution tests showed that the initial release of the 
drug from the compressed tablet was low for both 
formulations, indicating that the applied coating 
functioned as desired for taste masking (Fig 2). 
However, earlier onset of drug release from the 
irregular Compap granules tableting blend and 
chewable tablets indicated differences in coating 
effectiveness, resulting from the substrate 
morphology. The difference in drug released at 5 mins 
between coated Compap granules and compressed 
granules was 41% compared to 5% difference between 
the coated crystalline granules before and after 
compression. 
 
Fig. 2. Compap (blue) and Special (red) coated granules 
drug release before (……) and after compression (___). 
CONCLUSIONS 
In this study, drug particles were successfully coated 
with Surelease to provide the reduced initial drug 
release desirable for taste masking applications. The 
effect of substrate morphology and particle 
characteristics were found to be important in 
maintaining the integrity of the coating throughout 
the process of manufacturing chewable tablets. 
Raman microscopy was found to be a useful 
technique to visualize the integrity of barrier 
membrane at the various stage of chewable tablets 
development and to provide understanding of factors 
affecting drug release. 
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